To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

Condition:   Fibrodysplasia Ossificans Progressiva (FOP) Interventions:   Drug: INCB000928;   Drug: placebo Sponsor:   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials